Stocklytics Platform
Asset logo for symbol BTMD
Biote
BTMD75
$5.95arrow_drop_up2.76%$0.16
High Quality
Asset logo for symbol BTMD
BTMD75

$5.95

arrow_drop_up2.76%
Key Stats
Open$5.79
Prev. Close$5.79
EPS0.30
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$185.12M
LOWHIGH
Day Range5.63
5.95
52 Week Range3.65
8.44
Ratios
Revenue-
EPS0.30
Fundamentals
Debt/Equity Ratio-
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

BTMD-
US Healthcare Sector-
US Market-
check_circle

BTMD / Market

BTMD exceeded the US Market which returned 1.00% over the last twenty four hours.
warning

BTMD / Healthcare Sector

BTMD lose to the US Healthcare sector which returned 2.95% over the last twenty four hours.

Biote (BTMD) Statistics

Biote Corp (BTMD) is a company that operates in the biotechnology sector, focusing on the development of innovative medical solutions. As of the latest available data, the stock statistics of BTMD indicate its performance in the market. These statistics provide valuable insights into the company's stock price, trading volume, and other related metrics. Investors can use this information to analyze the historical performance of BTMD shares and make informed investment decisions.
In terms of valuation metrics, BTMD's stock is evaluated based on various factors such as its price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. These metrics help investors determine whether the current stock price is overvalued or undervalued. Similarly, fundamental analysis of BTMD involves examining key financial indicators like earnings per share, revenue growth, and net income. These fundamentals provide a deeper understanding of the company's financial health and growth prospects.
add Biote to watchlist

Keep an eye on Biote

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Biote (BTMD) stock's performance compared to its sector and the market over the past year?

Over the past year, Biote (BTMD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.34%, Biote has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 47.67%, it has fallen short of the market average. This comparison highlights Biote's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Biote (BTMD) stock?

The PE (Price to Earnings) ratio of Biote (BTMD) is currently 19.83. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Biote (BTMD) stock?

The Earnings Per Share (EPS) for Biote (BTMD), calculated on a diluted basis, is $0.3. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Biote (BTMD) stock?

The operating margin for Biote (BTMD) is 23.71%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Biote (BTMD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Biote (BTMD) is $38.29M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Biote (BTMD) have?

Biote (BTMD) has a total debt of $122.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$28.47M.

Take Your Investments to a Whole New Level